SEC Company Response from INNOCAN PHARMA (INNPF) — Sep 22, 2025
INNOCAN PHARMA Corp
Date: Sept. 22, 2025 · CIK: 0001889791 · Accession: 0001493152-25-014448
AI Filing Summary & Sentiment
File numbers found in text: 333-288899
Letter
Re: Innocan Pharma Corporation (CIK 0001889791)
September 22, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Registration Statement No. 333-288899 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), ThinkEquity LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on September 24, 2025, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very
truly yours,
ThinkEquity
LLC
Show Raw Text
CORRESP
1
filename1.htm
September
22, 2025
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Innocan
Pharma Corporation (CIK 0001889791)
Registration
Statement No. 333-288899 on Form F-1 (the “Registration Statement”)
Ladies
and Gentlemen:
In
accordance with Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), ThinkEquity LLC,
as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement
so that it will become effective at 5:00 p.m. Eastern Time on September 24, 2025, or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated
to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears
to be reasonable to secure adequate distribution of the preliminary prospectus.
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended,
in connection with the above-referenced issue.
Very
truly yours,
ThinkEquity
LLC
By:
/s/ Eric
Lord
Name:
Eric Lord
Title:
Head of Investment Banking